AGXT and myocardial infarction: Pharmacological inhibition of SPT was associated with reduced ventricularremodelling, fibrosis, and macrophage content following myocardial infarction,whereas genetic deletion of SPTLC2 preserved cardiac function followingmyocardial infarction [205, 206].